International Cannabis Weekly: 169

COVID-19 IMPACTING CBD PURCHASES ACROSS INTERNATIONAL MARKETS

The COVID-19 pandemic has effected change around the world, forcing the complete close-down of entire industries and the surprising growth of others.

The CBD market is one such market and, as highlighted in CBD: The Consumer Report, consumers across mature & emerging markets have reported an increase in consumption during the outbreak.

To understand how businesses can capitalise and adapt to the new normal, secure your copy of CBD: The Consumer Report, here.

READ MORE

HIGHLIGHTS

• NEW ZEALAND HEADS TO POLLS TO VOTE ON CANNABIS LEGALISATION THIS WEEKEND
• AGENDA HIGHLIGHTS REVEALED FOR PROHIBITION PARTNERS LIVE

• Amazon starts selling CBD products in the UK, under a pilot programme.
• German patient wins court case against insurer for medical cannabis reimbursement.
• NYSK Holdings opens medical cannabis production facility in North Macedonia.
• Ukrainian president may pose cannabis legalisation question in countrywide poll.
• Irish farmers urge the government to change cannabis laws regarding THC limits.

PROCAPITAL RETURNS

Prohibition Partners LIVE, in partnership with MAZAKALI, is delighted to return this November with ProCapital, an exclusive investment-focused platform showcasing the most exciting opportunities across the international plant-based medicines and psychedelics industries.

Limited spaces are available. Apply for more details.

LEARN MORE

• New polls show growing support for cannabis legalisation in Arizona and Montana.
• Illinois collects over US$100 million in tax revenue due to adult-use cannabis sales.
• Pennsylvania governor calls on lawmakers to legalise adult-use cannabis.
• New poll shows New Jersey voters back adult-use cannabis by a two-to-one margin.
• Mississippi governor signs bill allowing FDA-approved cannabis medications.
• Michigan governor signs legislation to expunge cannabis-related convictions.
• Maine’s first weekend of adult-use cannabis sales reach more than US$250,000.

• Barriers in the medical cannabis system force patients to self-medicate without support.
• Aphria report missed sales forecast.
• Canopy Growth announces new partnerships with Reyes Beer and Manhattan Beer.
• Alberta lifts the cap on the percentage of the cannabis market that retailers can own.
• Heritage Cannabis subsidiary CannaCure Corp receives Health Canada sales licence.

• Colombia’s Congress advances two bills to regulate adult-use cannabis.
• MGC Pharmaceuticals ships first high THC medicinal products directly to patients in Brazil.
• Mexico plans to legalise cannabis by 15 December 2020.
• Aurora sells Uruguayan assets amid billion-dollar losses.
• Buenos Aires Legislature begins debate on medicinal cannabis and self-cultivation bill.

• Colombia’s Congress advances two bills to regulate adult-use cannabis.
• MGC Pharmaceuticals ships first high THC medicinal products directly to patients in Brazil.
• Mexico plans to legalise cannabis by 15 December 2020.
• Aurora sells Uruguayan assets amid billion-dollar losses.
• Buenos Aires Legislature begins debate on medicinal cannabis and self-cultivation bill.
• Victoria will introduce legislation to allow medicinal cannabis users to drive.
• Little Green Pharma receives manufacturing licence for new cannabis facility.

• Rwanda legalises production and processing of medical cannabis for exports.
• Creso Pharma receives AU$630,000 in orders from South Africa for cannabis lozenges.
• Israel plans to launch a medical cannabis stock index on the Tel Aviv stock exchange.
• Israel’s IM Cannabis Corp files application to list on the NASDAQ.